No takes yet. Share an insight, caveat, or question.
Review explores genetic modification and manufacturing costs in viral vectors, suggesting optimization strategies for better gene therapy outcomes.
Shen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: